124 related articles for article (PubMed ID: 20706050)
1. A focal pulmonary F-18 FDG uptake without pulmonary CT abnormality in PET/CT probably due to mislocation of the urine F-18 FDG in the left upper renal calyx.
Tani A; Kajiya Y; Nakajo M; Nakajo M
Clin Nucl Med; 2010 Sep; 35(9):713-6. PubMed ID: 20706050
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
[TBL] [Abstract][Full Text] [Related]
3. Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT.
Karantanis D; Subramaniam RM; Mullan BP; Peller PJ; Wiseman GA
J Comput Assist Tomogr; 2007; 31(5):800-5. PubMed ID: 17895795
[TBL] [Abstract][Full Text] [Related]
4. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
5. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
[TBL] [Abstract][Full Text] [Related]
7. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
8. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
9. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
10. Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings.
Farsad M; Ambrosini V; Nanni C; Castellucci P; Boschi S; Rubello D; Fabbri M; Franchi R; Fanti S
Nucl Med Commun; 2005 Sep; 26(9):827-30. PubMed ID: 16096587
[TBL] [Abstract][Full Text] [Related]
11. Detection of an asymptomatic right-ventricle cardiac metastasis from a small-cell lung cancer by F-18-FDG PET/CT.
Orcurto MV; Delaloye AB; Letovanec I; Martins Favre M; Prior JO
J Thorac Oncol; 2009 Jan; 4(1):127-30. PubMed ID: 19096320
[TBL] [Abstract][Full Text] [Related]
12. Metastatic colon cancer to the lung with no detectable primary tumor, mimicking advanced primary lung cancer on F-18 FDG PET/CT imaging.
Kim HW; Won KS; Kwon KY; Choi BW; Zeon SK
Clin Nucl Med; 2010 Mar; 35(3):184-6. PubMed ID: 20173453
[TBL] [Abstract][Full Text] [Related]
13. Measurement of airway inflammation in current smokers by positron emission tomography.
Garpered S; Minarik D; Diaz S; Valind S; Edenbrandt L; Wollmer P
Clin Physiol Funct Imaging; 2019 Nov; 39(6):393-398. PubMed ID: 31278814
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT images.
Schreiter N; Nogami M; Buchert R; Froeling V; Brenner W; Diekmann F
Acta Radiol; 2011 Jun; 52(5):513-5. PubMed ID: 21498287
[TBL] [Abstract][Full Text] [Related]
15. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
[TBL] [Abstract][Full Text] [Related]
16. Incidental focal F-18 FDG accumulation in lung parenchyma without abnormal CT findings.
Ha JM; Jeong SY; Seo YS; Kwon SY; Chong A; Oh JR; Song HC; Bom HS; Min JJ
Ann Nucl Med; 2009 Aug; 23(6):599-603. PubMed ID: 19452248
[TBL] [Abstract][Full Text] [Related]
17. A case of secondary hemochromatosis with high uptake of liver in F-18 FDG PET/CT imaging.
Ito K; Minamimoto R; Morooka M; Kubota K
Clin Nucl Med; 2011 Jul; 36(7):606-8. PubMed ID: 21637075
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET/CT in the evaluation of anal carcinoma.
Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of physiologic uptake detected with true whole-body 18F-FDG PET/CT in healthy subjects.
Reinking MF; Osman MM
J Nucl Med Technol; 2009 Mar; 37(1):31-7. PubMed ID: 19223428
[TBL] [Abstract][Full Text] [Related]
20. Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma.
Querellou S; Keromnes N; Abgral R; Sassolas B; Le Roux PY; Cavarec MB; Le Duc-Pennec A; Couturier O; Salaun PY
Nucl Med Commun; 2010 Sep; 31(9):766-72. PubMed ID: 20585271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
